Thank you to Teva Pharmaceuticals

106 0

HD Insights thanks Teva for its ongoing support

Teva CNS is committed to continued research and development of its product portfolio and to the development of medicines aimed at meeting the specific needs of the patient communities it serves. Teva’s legacy in CNS is grounded in its commitment to ongoing collaboration with academia, medical institutions and patient advocacy groups to find innovative solutions for patients who live with chronic and debilitating diseases.

Leave a comment

Your email address will not be published. Required fields are marked *

Related Post

Editor’s Letter

January 1, 2015 0
Welcome to the 10th edition of HD Insights, timed for the beginning of CHDI’s 10th Annual HD Therapeutics Conference. We…

HD Insights Volume 1 (PDF)

November 3, 2011 0
[pdf-embedder url=”http://huntingtonstudygroup.org/wp-content/uploads/2016/05/vol-1-fall-2011.pdf”]

Highlights of HSG 2014

January 1, 2015 0
By: Meredith A. Achey, BM HSG 2014 highlighted “Ideas for the future” of the HSG, exploring education, innovation, and discovery…

HD Insights Volume 9 (PDF)

April 23, 2014 0
[pdf-embedder url=”http://huntingtonstudygroup.org/wp-content/uploads/2016/05/vol-9-winter-2014.pdf”]